Low birthweight Clinical Trials

8 recruitingLast updated: May 13, 2026

There are 8 actively recruiting low birthweight clinical trials across 10 countries. Studies span Not Applicable, Phase 4. Top locations include Ballary, Karnataka, India, Belagavi, Karnataka, India, Berlin-Spandau, Germany. Updated daily from ClinicalTrials.gov.


Low birthweight Trials at a Glance

8 actively recruiting trials for low birthweight are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Ballary, Belagavi, and Berlin-Spandau. Lead sponsors running low birthweight studies include Duke University, Harvard School of Public Health (HSPH), and Aga Khan University.

Browse low birthweight trials by phase

Treatments under study

About Low birthweight Clinical Trials

Looking for clinical trials for Low birthweight? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Low birthweight trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Low birthweight clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Accountability for Care Through Undoing Racism & Equity for Moms

Maternal mortalityLow birthweightPregnancy Related+3 more
University of North Carolina, Chapel Hill60,000 enrolled1 locationNCT05484804
Recruiting
Phase 4

Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics

Low birthweightPregnancyPreterm Birth+6 more
Duke University2,500 enrolled2 locationsNCT05757167
Recruiting
Not Applicable

LIFT-UP: Randomized Controlled Trial of Fortification of Human Milk

very low birthweightVery Preterm Infant
Harvard School of Public Health (HSPH)776 enrolled4 locationsNCT06765863
Recruiting
Not Applicable

Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs)

Premature InfantLow Birthweight Infant
Société des Produits Nestlé (SPN)188 enrolled6 locationsNCT06212427
Recruiting
Not Applicable

Enhancing the Survival of Low Birth Weight Infants in Low-Resource Settings

Low birthweightPretermKangaroo Mother Care
University of South Carolina328 enrolled2 locationsNCT06937580
Recruiting

Exploring Minor Proteins and Peptides in Human Milk: a Proteomic Analysis Across Lactation Stages

PretermLow Birthweight InfantVery Low Birth Weight Preterms
Maimónides Biomedical Research Institute of Córdoba150 enrolled2 locationsNCT06787963
Recruiting
Not Applicable

Impact of Benazir Nashonuma Program (BNP) on Maternal and Child Nutritional Status

wastingLow birthweightStunting+3 more
Aga Khan University5,500 enrolled1 locationNCT05836961
Recruiting

A trial to evaluate the impact of an early start to iron/folic acid supplementation in pregnancy on deaths of newborns in rural Bangladesh

Preterm deliveryLow birthweight
The University of Sydney32,000 enrolled1 locationACTRN12612000588897